Highest Price Target1
Lowest Price Target1
Consensus Price Target1
Analyst Rating Summary1
| Buy | Overweight | Hold | Underweight | Sell |
|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 |
Analyst Firms Making Recommendations1
- Benchmark
- Keybanc
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Harvard Bioscience
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 06/22/2023 | HBIO | Buy Now | Harvard Bioscience | $5.22 | 34.1% | Benchmark | Bruce Jackson | → $7 | Reiterates | Speculative Buy → Speculative Buy | Get Alert |
| 04/26/2023 | HBIO | Buy Now | Harvard Bioscience | $5.22 | 34.1% | Benchmark | Bruce Jackson | $4 → $7 | Maintains | Buy | Get Alert |
| 04/26/2023 | HBIO | Buy Now | Harvard Bioscience | $5.22 | 34.1% | Keybanc | Paul Knight | $5 → $7 | Maintains | Overweight | Get Alert |
| 03/10/2023 | HBIO | Buy Now | Harvard Bioscience | $5.22 | -23.37% | Benchmark | Kenneth Bruce | → $4 | Reiterates | → Buy | Get Alert |
| 11/09/2022 | HBIO | Buy Now | Harvard Bioscience | $5.22 | -4.21% | Keybanc | Paul Knight | $7 → $5 | Maintains | Overweight | Get Alert |
| 08/05/2022 | HBIO | Buy Now | Harvard Bioscience | $5.22 | 34.1% | Keybanc | Paul Knight | $10 → $7 | Maintains | Overweight | Get Alert |
What is the target price for Harvard Bioscience (HBIO)?
The latest price target for Harvard Bioscience (NASDAQ: HBIO) was reported by Benchmark on June 22, 2023. The analyst firm set a price target for $7.00 expecting HBIO to rise to within 12 months (a possible 34.10% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Harvard Bioscience (HBIO)?
The latest analyst rating for Harvard Bioscience (NASDAQ: HBIO) was provided by Benchmark, and Harvard Bioscience reiterated their speculative buy rating.
When is the next analyst rating going to be posted or updated for Harvard Bioscience (HBIO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Harvard Bioscience, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Harvard Bioscience was filed on June 22, 2023 so you should expect the next rating to be made available sometime around June 22, 2024.
Is the Analyst Rating Harvard Bioscience (HBIO) correct?
While ratings are subjective and will change, the latest Harvard Bioscience (HBIO) rating was a reiterated with a price target of $0.00 to $7.00. The current price Harvard Bioscience (HBIO) is trading at is $5.22, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.